PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2009American Journal of Clinical Pathology126 citations

Assessment of Platelet Function on Whole Blood by Multiple Electrode Aggregometry in High-Risk Patients With Coronary Artery Disease Receiving Antiplatelet Therapy

View Full Paper
RPRita PanicciaUniversity of FlorenceEAEmilia AntonucciANT Foundation Italy OnlusNMNiccolò MagginiAzienda Ospedaliero-Universitaria Careggi

Structured PICO

Does Multiplate impedance platelet aggregometry correlate with light transmission aggregometry and PFA-100 for assessing residual platelet reactivity in ACS patients on dual antiplatelet therapy?

P
Population
297 patients with acute coronary syndrome receiving dual antiplatelet therapy
I
Intervention
Multiplate impedance platelet aggregometry (IPA)
C
Comparator
Light transmission aggregometry (LTA) and PFA-100
O
Outcome
Correlation and agreement between Multiplate IPA and LTA/PFA-100 for determining residual platelet reactivitysurrogate

Multiplate impedance platelet aggregometry correlates well with standard methods like LTA and PFA-100, offering a reliable and rapid tool for monitoring antiplatelet therapy in clinical practice.

Abstract

This study sought to compare Multiplate impedance platelet aggregometry (IPA) with light transmission aggregometry (LTA) and the PFA-100 for determining the prevalence of residual platelet reactivity (RPR) by the Multiplate IPA in 297 patients with acute coronary syndrome receiving dual antiplatelet therapy. Aggregations were induced by adenosine-5 diphosphate (ADP), arachidonic acid, and collagen. PFA-100 closure times were measured by collagen and ADP and epinephrine (CEPI) cartridges. Significant correlations were observed between Multiplate IPA and LTA after all stimulations (P < .0001) and between Multiplate IPA (arachidonate and collagen) and PFA-100 CEPI closure time (P < .0001 for both). Cutoff values of Multiplate IPA (for all stimulations) were calculated for the identification of RPR. Between the Multiplate IPA and LTA good agreement was found with all 3 agonists (P < .0001 for all). Multiplate IPA might represent a reliable, handy, rapid tool to monitor antiplatelet therapy in clinical practice and for clinical investigations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Paniccia et al. (2009) studied this question.

synapsesocial.com/papers/6a81b484f5c53425b9e19e13https://doi.org/10.1309/ajcpte3k1sgapoiz
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Variables influencing Multiplate™ whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals2007 · 163 citations
  2. 2Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients2010 · 77 citations
  3. 3Point-of-Care Whole Blood Impedance Aggregometry Versus Classical Light Transmission Aggregometry for Detecting Aspirin and Clopidogrel: The Results of a Pilot Study2008 · 116 citations
  4. 4Comparing light transmission aggregometry and PFA100 for monitoring antiplatelet therapy in patients with coronary heart disease2016 · 1 citations
  5. 5Electric impedance platelet aggregometry in cardiac surgery patients: A comparative study of two technologies2015 · 16 citations